4.26
price down icon27.05%   -1.58
pre-market  Pre-mercato:  4.65   0.39   +9.15%
loading

Perché le azioni Jaguar Health Inc (JAGX) sono in ribasso?

Abbiamo notato un calo di 27.05% nelle azioni di Jaguar Health Inc (JAGX) durante la sessione di negoziazione di 2025-05-21. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-21:

Jaguar Health Inc Stock (JAGX) dropped by 24.81% from $0.462 to $0.3474 in the trading on Tuesday November 21, 2023. The reason why JAGX stock down today is due to the update on Phase 3 trial for plant-based drug. Jaguar Health announced that its subsidiary, Napo Pharmaceuticals, is yet to receive topline results from its OnTarget Phase 3 trial for the plant-based drug Crofelemer. This pivotal study aims to assess Crofelemer's efficacy as a preventive treatment for cancer therapy-related diarrhea in adults. While topline results are expected soon, Jaguar Health (JAGX) refrained from providing a specific timeline.

$1.30
price down icon 1.52%
$584.95
price up icon 1.15%
$32.59
price down icon 0.12%
$4.01
price down icon 4.52%
$292.58
price up icon 0.31%
$74.09
price down icon 0.86%
Capitalizzazione:     |  Volume (24 ore):